SCHEMBL5887334

SCHEMBL5887334

COc1ccc(CNC(=O)c2ccc(-n3c(=O)ccc4c(C)nc(N5CCN(C(=O)c6cccnc6)CC5)nc43)cc2)cc1OC

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 4/20 0.44
USP2 O75604 1/20 0.44
NPSR1 Q6W5P4 1/20 0.44
L3MBTL1 Q9Y468 1/20 0.44
KDM4E B2RXH2 1/20 0.43
MAPK1 P28482 1/20 0.43
POLB P06746 1/20 0.42
MAPT P10636 1/20 0.41
ACHE P22303 1/20 0.40
BACE1 P56817 1/20 0.40
ROCK2 O75116 1/20 0.40
NPC1 O15118 1/20 0.40
GFER P55789 1/20 0.40
SMN1; SMN2 Q16637 3/20 0.40
LMNA P02545 1/20 0.40
GAA P10253 1/20 0.40
HTT P42858 1/20 0.40
THRB P10828 1/20 0.39
NAMPT P43490 1/20 0.39
CYP1A2 P05177 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5887006 0.93 ACHE (0.48) ALDH1A1MAPK1MAPTACHEBACE1
SCHEMBL5887505 0.90 MGAM (0.41) ALDH1A1POLBMAPTSMN1; SMN2LMNA
SCHEMBL5887467 0.89 KDM4E (0.46) ALDH1A1KDM4EMAPK1POLBMAPT
SCHEMBL5887085 0.89 HTT (0.41) ALDH1A1POLBMAPTSMN1; SMN2LMNA
SCHEMBL5887048 0.89 MAPT (0.42) ALDH1A1NPSR1MAPTSMN1; SMN2HTT
SCHEMBL5886765 0.88 MAPT (0.48) ALDH1A1MAPTNPC1GFERSMN1; SMN2
SCHEMBL5886825 0.88 NPC1 (0.45) ALDH1A1L3MBTL1KDM4EMAPK1MAPT
SCHEMBL5886766 0.88 NPC1 (0.45) ALDH1A1MAPTNPC1GFERSMN1; SMN2
SCHEMBL5887201 0.87 KDM4E (0.47) ALDH1A1KDM4EMAPK1MAPTACHE
SCHEMBL5887563 0.87 EPHX2 (0.42) ALDH1A1MAPTROCK2LMNAHTT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7019002-B2 Substituted on 8th position with benzoic acid, ester or amide groups; anticancer agents PHARMACIA & UPJOHN, S.P.A. (IT) 2006-03-28 US claimed
US-20040009993-A1 Pyridopyrimidinones derivatives as telomerase inhibitors PHARMACIA ITALIA S.P.A. 2004-01-15 US claimed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040009993-A1 Pyridopyrimidinones derivatives as telomerase inhibitors TERT, TERF2, TERF2IP ALDH1A1 1860/4885USP2 3140/4885NPSR1 4843/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.